![Bradley Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Campbell
President på
Scioderm, Inc.
Profil
Bradley Lewis Campbell is currently Director at Amicus Therapeutics UK Ltd., Director at Biotechnology Innovation Organization, Co-President at Scioderm, Inc., and Trustee at New Jersey Health Initiatives.
Former roles include President, Chief Executive Officer & Director at Amicus Therapeutics, Inc. from 2022 to 2026; Independent Director at Progenics Pharmaceuticals, Inc. from 2016 to 2020; Business Director-Cardiac Gene Therapy Programs at Genzyme Corp.
from 2002 to 2006; Director at BioNJ, Inc.; Director at Alliance for Regenerative Medicine; Independent Director at ARYA Sciences Acquisition Corp.
III; Director at Gennao Bio, Inc.; and President at National Tay-Sachs & Allied Diseases Association.
Education includes an MBA from Harvard Business School, conferred in 2002.
Aktiva positioner av Bradley Campbell
| Företag | Position | Start |
|---|---|---|
New Jersey Health Initiatives | Direktör/Styrelseledamot | - |
Amicus Therapeutics UK Ltd.
 Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktör/Styrelseledamot | - |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | President | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Bradley Campbell
| Företag | Position | Slut |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Verkställande Direktör | 2026-04-27 |
| PROGENICS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2020-06-19 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | 2006-01-01 |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Direktör/Styrelseledamot | - |
| ARYA SCIENCES ACQUISITION III A | Direktör/Styrelseledamot | - |
Bradley Campbells utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
80
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
National Tay-Sachs & Allied Diseases Association
 National Tay-Sachs & Allied Diseases Association Miscellaneous Commercial ServicesCommercial Services Operates as an association for providing funding, research, and support services for individual affected with Tay-Sachs, Canavan, Sandhoff, GM1 gangliosidosis, and related diseases | Commercial Services |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
New Jersey Health Initiatives | |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
